Hot Features
| Actionnaire | Type | Détenues (Réel) | % en Circulation | Valeur Marchande | Date de Reporte |
|---|---|---|---|---|---|
| Paragon Therapeutics, Inc. | Institution | 5 000 000 | 15,05% | US$ 92,25M | 2025-04-15 |
| FMR LLC | Institution | 4 133 514 | 12,44% | US$ 76,26M | 2026-03-31 |
| BVF Partners L.P. | Institution | 2 748 763 | 8,27% | US$ 50,71M | 2026-03-31 |
| Fairmount Funds Management LLC | Institution | 2 747 866 | 8,27% | US$ 50,70M | 2026-03-31 |
| Fairmount Healthcare Fund II L.P. | Institution | 2 747 866 | 8,27% | US$ 50,70M | 2025-12-04 |
| VR Management, LLC | Institution | 2 133 576 | 6,42% | US$ 39,36M | 2026-03-31 |
| Venrock Healthcare Capital Partners EG, L.P. | Institution | 1 692 687 | 5,09% | US$ 31,23M | 2025-12-31 |
| Forbion Capital Partners B.V. | Institution | 1 677 852 | 5,05% | US$ 30,96M | 2026-03-31 |
| Forbion Growth Opportunities Fund III Cooperatief U.A. | Institution | 1 677 852 | 5,05% | US$ 30,96M | 2025-12-08 |
| Balyasny Asset Management L.P. | Institution | 1 510 033 | 4,54% | US$ 27,86M | 2026-03-31 |
| Vestal Point Capital, LP | Institution | 1 500 000 | 4,51% | US$ 27,68M | 2026-03-31 |
| Jiaqiang Li | Initiés | 1 425 432 | 4,29% | US$ 26,30M | 2025-10-07 |
| Opaleye Management Inc. | Institution | 1 312 615 | 3,95% | US$ 24,22M | 2026-03-31 |
| Tang Capital Management, LLC | Institution | 1 160 000 | 3,49% | US$ 21,40M | 2026-03-31 |
| Atlas Diversified Master Fund, Ltd. | Institution | 840 033 | 2,53% | US$ 15,50M | 2026-03-31 |
| Vanguard Capital Management, LLC | Institution | 801 395 | 2,41% | US$ 14,79M | 2026-03-31 |
| Biotechnology Value Fund L.P. | Institution | 707 116 | 2,13% | US$ 13,05M | 2025-06-30 |
| Biotechnology Value Fund II, L.P. | Institution | 593 740 | 1,79% | US$ 10,95M | 2025-06-30 |
| Logos Global Management, L.P. | Institution | 482 500 | 1,45% | US$ 8,90M | 2026-03-31 |
| Deep Track Capital, LP | Institution | 453 686 | 1,37% | US$ 8,37M | 2026-03-31 |
| Boxer Capital Management, LLC | Institution | 453 686 | 1,37% | US$ 8,37M | 2026-03-31 |
| Venrock Healthcare Capital Partners III, L.P. | Institution | 400 788 | 1,21% | US$ 7,39M | 2025-12-31 |
| Tang Capital Partners, LP | Institution | 393 681 | 1,18% | US$ 7,26M | 2025-10-02 |
| RTW Investments, LP | Institution | 372 856 | 1,12% | US$ 6,88M | 2026-03-31 |
| Nextbio Capital Management Lp | Institution | 372 856 | 1,12% | US$ 6,88M | 2026-03-31 |
| Remedium Capital Partners, Llc | Institution | 361 250 | 1,09% | US$ 6,67M | 2026-03-31 |
| Millennium Management LLC | Institution | 323 553 | 0,97% | US$ 5,97M | 2026-03-31 |
| Tang Capital Partners International, LP | Institution | 306 319 | 0,92% | US$ 5,65M | 2025-10-02 |
| T. Rowe Price Group, Inc. | Institution | 303 551 | 0,91% | US$ 5,60M | 2026-03-31 |
| Point72 Asset Management, L.P. | Institution | 300 000 | 0,90% | US$ 5,54M | 2026-03-31 |
| Alyeska Investment Group, L.P. | Institution | 264 000 | 0,79% | US$ 4,87M | 2026-03-31 |
| The Goldman Sachs Group, Inc. | Institution | 228 475 | 0,69% | US$ 4,22M | 2026-03-31 |
| Susquehanna International Group, LLP | Institution | 213 635 | 0,64% | US$ 3,94M | 2026-03-31 |
| Perceptive Advisors LLC | Institution | 206 942 | 0,62% | US$ 3,82M | 2026-03-31 |
| Marshall Wace LLP | Institution | 200 780 | 0,60% | US$ 3,70M | 2026-03-31 |
| Exome Asset Management LLC | Institution | 153 191 | 0,46% | US$ 2,83M | 2026-03-31 |
| Jennison Associates LLC | Institution | 152 974 | 0,46% | US$ 2,82M | 2026-03-31 |
| Silverarc Capital Management, LLC | Institution | 130 500 | 0,39% | US$ 2,41M | 2026-03-31 |
| Two Sigma Investments, LP | Institution | 115 828 | 0,35% | US$ 2,14M | 2026-03-31 |
| BlackRock, Inc. | Institution | 115 725 | 0,35% | US$ 2,14M | 2026-03-31 |
| Geode Capital Management, LLC | Institution | 104 221 | 0,31% | US$ 1,92M | 2026-03-31 |
| Logos Global Master Fund, LP | Institution | 100 000 | 0,30% | US$ 1,85M | 2025-06-30 |
| Hudson Bay Capital Management LP | Institution | 88 867 | 0,27% | US$ 1,64M | 2026-03-31 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.